Zai Lab Limited (ZLAB)
NASDAQ: ZLAB · Real-Time Price · USD
18.18
+0.30 (1.68%)
At close: Jun 18, 2026, 4:00 PM EDT
18.16
-0.02 (-0.11%)
After-hours: Jun 18, 2026, 5:52 PM EDT
Zai Lab Employees
Zai Lab had 1,784 employees as of December 31, 2025. The number of employees decreased by 85 or -4.55% compared to the previous year.
Employees
1,784
Change (1Y)
-85
Growth (1Y)
-4.55%
Revenue / Employee
$254,081
Profits / Employee
-$99,840
Market Cap
2.04B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1,784 | -85 | -4.55% | 1,784 | 0 |
| Dec 31, 2024 | 1,869 | -306 | -14.07% | 1,869 | 0 |
| Dec 31, 2023 | 2,175 | 139 | 6.83% | 2,175 | 0 |
| Dec 31, 2022 | 2,036 | 85 | 4.36% | 2,036 | 0 |
| Dec 31, 2021 | 1,951 | 757 | 63.40% | 1,951 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Ocular Therapeutix | 325 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Immunome | 206 |
| Aurinia Pharmaceuticals | 128 |
ZLAB News
- 1 day ago - Zai Lab Transcript: AGM 2026 - Transcripts
- 2 days ago - Zai Lab announces EMA granted ODD to zocilurtatug pelitecan - TheFly
- 2 days ago - Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas - Business Wire
- 9 days ago - Zai Lab (ZLAB) Gains Approval for Tivdak in Cervical Cancer Treatment - GuruFocus
- 9 days ago - Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer - Business Wire
- 17 days ago - Zai Lab (ZLAB) Q1 2026 Earnings Transcript - The Motley Fool
- 27 days ago - Zai Lab (ZLAB) Announces Leadership Change Amid Strategic Developments - GuruFocus
- 4 weeks ago - Zai Lab announces departure of COO Josh Smiley - TheFly